Medicare Enrolled
Dr. Ali Ashtiani, M.D.
Interventional Cardiology · Santa Ana, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ashtiani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ashtiani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ashtiani
Dr. Ali Ashtiani is an interventional cardiology specialist in Santa Ana, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Ashtiani performed 1,879 Medicare services across 1,313 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ashtiani received a total of $8,635 from 36 pharmaceutical and/or device companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ashtiani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ 1,879 Medicare services
$8,635 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,879
Medicare services
Bottom 42% in CA for interventional cardiology
1,313
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~171 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
339 | $71 | $132 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
259 | $66 | $113 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
197 | $11 | $50 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
172 | $41 | $80 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
150 | $140 | $315 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $108 | $260 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
103 | $163 | $376 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 82 | $408 | $680 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
57 | $21 | $43 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
54 | $100 | $162 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
49 | $61 | $180 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
41 | $1,341 | $2,385 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
40 | $10 | $20 |
| Cardiac catheterization | 36 | $193 | $490 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
31 | $134 | $266 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $75 | $176 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
20 | $11 | $24 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
19 | $17 | $36 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
19 | $84 | $554 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
15 | $239 | $724 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
14 | $46 | $157 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
14 | $22 | $94 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
14 | $210 | $426 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
13 | $91 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.1% high complexity
21.6% medium
70.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,635
Total received (2018-2024)
Avg $1,234/year across 7 years
Top 44% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
304
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,635 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,398
2023
$2,758
2022
$2,125
2021
$667
2020
$45
2019
$334
2018
$308
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$409
Novartis Pharmaceuticals Corporation
$276
AstraZeneca Pharmaceuticals LP
$225
Boehringer Ingelheim Pharmaceuticals, Inc.
$201
Merck Sharp & Dohme LLC
$146
Janssen Pharmaceuticals, Inc
$133
Alnylam Pharmaceuticals Inc.
$129
CARDIVA MEDICAL, INC.
$105
E.R. Squibb & Sons, L.L.C.
$98
Novo Nordisk Inc
$84
PFIZER INC.
$79
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$74
Bayer Healthcare Pharmaceuticals Inc.
$72
Kiniksa Pharmaceuticals International, plc
$71
Amgen Inc.
$69
ABIOMED
$47
SCPHARMACEUTICALS INC.
$43
Kestra Medical Technology Services, Inc.
$35
Boston Scientific Corporation
$33
Medtronic, Inc.
$26
Lilly USA, LLC
$23
Abbott Laboratories
$19
Top 3 companies account for 37.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$771
Abbott Laboratories
$771
Merck Sharp & Dohme LLC
$581
Medtronic, Inc.
$476
Impulse Dynamics (USA) Inc.
$471
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$417
ShockWave Medical, Inc
$409
Boehringer Ingelheim Pharmaceuticals, Inc.
$405
AstraZeneca Pharmaceuticals LP
$383
Alnylam Pharmaceuticals Inc.
$340
Edwards Lifesciences Corporation
$339
ABIOMED
$327
Janssen Pharmaceuticals, Inc
$302
BIOTRONIK INC.
$280
PFIZER INC.
$267
Cardiovascular Systems Inc.
$249
Novo Nordisk Inc
$245
E.R. Squibb & Sons, L.L.C.
$227
Penumbra, Inc.
$157
Medtronic Vascular, Inc.
$154
Amgen Inc.
$140
CARDIVA MEDICAL, INC.
$137
Boston Scientific Corporation
$132
SANOFI-AVENTIS U.S. LLC
$117
Biosense Webster, Inc.
$104
Bayer Healthcare Pharmaceuticals Inc.
$72
Kiniksa Pharmaceuticals International, plc
$71
SCPHARMACEUTICALS INC.
$67
Kestra Medical Technology Services, Inc.
$55
Siemens Medical Solutions USA, Inc.
$40
Baxter Healthcare
$27
CVRx, Inc.
$25
Merck Sharp & Dohme Corporation
$25
Lilly USA, LLC
$23
Esperion Therapeutics, Inc.
$16
Lantheus Medical Imaging, Inc.
$14
Top 3 companies account for 24.6% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · AVEIR · Absolute Pro vascular stent system · Acticor 7 VR-T DX · Adapta · Arcalyst · Assure WCD · Azure · Barostim Neo System · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CONFIRM RX · COREVALVE EVOLUT R · CardioMEMS HF System · CoreValve Evolut · Coronary Orbital Atherectomy System · DEFINITY · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Embozene · Ensite Cardiac Mapping System · FARXIGA · FUROSCIX · Hillrom - Carnation Ambulatory Monitor · Iforia 5 VR-T DX · Impella · Indigo System · JARDIANCE · Kerendia · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MitraClip System · NEXLETOL · OCTARAY MAPPING CATHETER · ONPATTRO · OPTIMIZER · OPTOWIRE · Ozempic · PRADAXA · PRALUENT · QUADRA ASSURA · Repatha · Saxenda · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TYRX · VERQUVO · VYNDAQEL · WAINUA · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIENCE SIERRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
55
Per 100K population
1.7
County median income
$113,702
Nearest hospital
ORANGE COUNTY GLOBAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ashtiani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ashtiani experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ashtiani performed 339 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ashtiani receive payments from pharmaceutical companies?
Yes. Dr. Ashtiani received a total of $8,635 from 36 companies across 304 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ashtiani's costs compare to other interventional cardiologists in Santa Ana?
Dr. Ashtiani's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ashtiani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Santa Ana
Browse interventional cardiologists in Santa Ana ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology